Sanofi Acquires Pluromed To Commercialize Surgical Gel
French pharmaceutical giant Sanofi-Aventis plans to scoop up Massachusetts-based Pluromed Inc. to expand its own biosurgery offerings and give the medical device maker enough financial backing to commercialize one of its...To view the full article, register now.
Already a subscriber? Click here to view full article